These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 18187941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R, Polkinghorne KR, Kerr PG.
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [Abstract] [Full Text] [Related]

  • 6. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
    Naganuma T, Sugimura K, Uchida J, Tashiro K, Yoshimura R, Takemoto Y, Nakatani T.
    Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
    [Abstract] [Full Text] [Related]

  • 7. Effects of diabetes mellitus, chronic renal failure and hemodialysis on serum and salivary antioxidant status.
    Ben-Zvi I, Green Y, Nakhoul F, Kanter Y, Nagler RM.
    Nephron Clin Pract; 2007 Apr; 105(3):c114-20. PubMed ID: 17199094
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A circulating beta 2-microglobulin intermediate in hemodialysis patients.
    Uji Y, Motomiya Y, Ando Y.
    Nephron Clin Pract; 2009 Apr; 111(3):c173-81. PubMed ID: 19194107
    [Abstract] [Full Text] [Related]

  • 12. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
    Ota T, Umeda H, Yokota S, Miyata S, Takamura A, Sugino S, Hayashi K, Ishiki R, Takeichi Y, Iwase M, Inagaki H, Murohara T.
    Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
    [Abstract] [Full Text] [Related]

  • 13. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S, Kümpers P, Hellpap J, Horn R, Leitolf H, Haller H, Kielstein JT.
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
    Okuno S, Ishimura E, Kohno K, Fujino-Katoh Y, Maeno Y, Yamakawa T, Inaba M, Nishizawa Y.
    Nephrol Dial Transplant; 2009 Feb; 24(2):571-7. PubMed ID: 18799606
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beta-2-microglobulin kinetics during paired filtration dialysis.
    Kes P, Zubcić A, Ratković-Gusić I, Prsa M.
    Acta Med Croatica; 1998 Feb; 52(2):99-102. PubMed ID: 9682496
    [Abstract] [Full Text] [Related]

  • 20. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
    Hei ZQ, Li XY, Shen N, Pang HY, Zhou SL, Guan JQ.
    Chin Med J (Engl); 2008 Jul 20; 121(14):1251-6. PubMed ID: 18713542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.